The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...

Key opportunities lie in reagents & consumables due to their high usage, drug discovery's large market share, and significant ...

Inflammatory bowel disease (IBD) is a progressive, recurrent gastrointestinal disorder influenced by genetic, immunoregulatory and environmental factors and often requiring surgery for treatment.

Microarray-based analysis of gene expression requires the assembly of a complex system of biological reagents, hardware, software and laboratory and analytic procedures. A variety of reported ...

The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...